Translate Bio, Inc. is an early-clinical-stage biotechnology company developing mRNA therapeutics and vaccines targeting protein or gene dysfunction and infectious diseases respectively. Translate Bio ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) today announced key management and board appointments in advance of the company’s planned separation, targeted for mid-October, ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...
Hosted on MSN
Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation
Management projects "revenue growth of at least 8% over 2025 with Q1 2026 revenue of approximately $18.5 million." Koblish explained the guidance: "Given the change that we've implemented -- wholesale ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Iveric Bio management will participate in fireside chats at the following investor conferences in November: ...
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) announced that its management team will participate in two upcoming investor conferences in February and March, where executives will deliver ...
Propel Bio Partners is a leading global venture fund specializing in life science investments, offering a comprehensive ecosystem of experts to empower entrepreneurs to realize their visions. Richard ...
LOS ANGELES, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio” or the “Company”), a biopharmaceutical company pioneering Tissue Specific Therapeutics (TSTx)™ targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results